Onartuzumab
| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Humanized (from mouse) |
| Target | scatter factor receptor kinase |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C4422H6820N1168O1363S31 |
| Molar mass | 99147.88 g·mol−1 |
| (what is this?) (verify) | |
Onartuzumab is a humanized monoclonal antibody designed for the treatment of advanced non-small-cell lung cancer.
Onartuzumab was developed by Genentech, Inc. It is undergoing clinical trials.